DNIB Unwind Inc Stock OTC Bulletin Board
Equities
BINDQ
US05548N1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 16-07-23 |
1st Jan change | Capi. | |
---|---|---|
-3.40% | 102B | |
+1.33% | 96.09B | |
+2.13% | 22.28B | |
-16.68% | 21.4B | |
-8.98% | 18.14B | |
-39.98% | 17.02B | |
-13.97% | 16.09B | |
+5.94% | 13.83B | |
+33.67% | 11.97B |
- Stock Market
- Equities
- BINDQ Stock
- BINDQ Stock